JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF Rating $55.35 +0.00 (+0.01%) As of 08/27/2025 Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HEQQ Aggregate RatingModerate Buy 2.81Holdings in HEQQ have an aggregate rating of Moderate Buy based on 726 analyst ratings issued in the past year covering 24 companies (75.6% of the portfolio).HEQQ Aggregate Price Target$55.35High Prediction$55.35Average Prediction$55.35Low Prediction$55.35Holdings in HEQQ have an aggregate price target of $55.35 and a range of $55.35 to $55.35 covering 24 companies (75.6% of the portfolio).HEQQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 HEQQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.79%NVDANVIDIA$180.17-0.8%4.8902 of 5 stars2.93$206.54 14.6%44Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision10.11%MSFTMicrosoft$509.64+0.6%4.8895 of 5 stars2.97$612.54 20.2%32Trending NewsAnalyst Revision8.16%AAPLApple$232.56+0.9%4.5347 of 5 stars2.57$237.37 2.1%30Trending NewsAnalyst Forecast5.79%AMZNAmazon.com$231.60+1.1%4.5372 of 5 stars3.00$262.87 13.5%50Trending NewsInsider Trade5.66%AVGOBroadcom$308.65+2.8%4.7863 of 5 stars3.07$301.79 -2.2%30Trending NewsUpcoming EarningsAnalyst Forecast5.10%GOOGAlphabet$212.37+2.0%4.5979 of 5 stars2.77$215.19 1.3%31Trending News4.34%METAMeta Platforms$751.11+0.5%3.9752 of 5 stars2.96$822.41 9.5%47Trending NewsInsider TradeAnalyst Revision3.35%NFLXNetflix$1,231.45+0.6%4.0972 of 5 stars2.58$1,297.66 5.4%36Trending News2.86%TSLATesla$345.98-1.0%4.3263 of 5 stars2.24$303.31 -12.3%42Trending NewsInsider Trade2.06%COSTCostco Wholesale$944.96-0.5%4.612 of 5 stars2.63$1,050.00 11.1%27Positive NewsAnalyst Forecast1.87%AMDAdvanced Micro Devices$168.58+0.9%4.2862 of 5 stars2.76$181.33 7.6%38Trending NewsAnalyst UpgradeInsider Trade1.87%PLTRPalantir Technologies$158.12+0.9%1.8353 of 5 stars2.09$136.61 -13.6%22Trending News1.64%ADIAnalog Devices$254.25-0.5%4.7566 of 5 stars2.85$273.53 7.6%26Insider TradeAnalyst Revision1.60%INTUIntuit$668.20+0.8%4.8538 of 5 stars2.84$797.62 19.4%25Earnings ReportInsider Trade1.36%BKNGBooking$5,651.99+0.6%4.4503 of 5 stars2.78$5,781.04 2.3%32Positive News1.28%LRCXLam Research$104.09+0.4%4.5141 of 5 stars2.74$107.30 3.1%27Positive NewsDividend IncreaseAnalyst Revision1.12%KOCocaCola$68.39-0.6%4.8072 of 5 stars3.06$77.21 12.9%17Positive News1.07%SNPSSynopsys$612.17+1.5%4.5134 of 5 stars2.92$634.64 3.7%13Positive NewsAnalyst Forecast0.95%JNJJohnson & Johnson$175.50-0.7%4.8746 of 5 stars2.65$176.29 0.4%20Positive NewsOptions Volume0.95%MUMicron Technology$122.00+3.6%4.9458 of 5 stars2.83$147.54 20.9%29Trending NewsAnalyst Forecast0.94%PANWPalo Alto Networks$191.02+1.8%4.3931 of 5 stars2.63$211.52 10.7%41Positive News0.92%NXPINXP Semiconductors$239.07+0.6%4.5963 of 5 stars2.95$256.05 7.1%20Positive NewsDividend Announcement0.88%MDLZMondelez International$61.28-0.8%4.842 of 5 stars2.65$72.00 17.5%20Positive News0.88%REGNRegeneron Pharmaceuticals$579.61-1.3%4.8501 of 5 stars2.81$817.67 41.1%27Trending NewsAnalyst Forecast This page (NASDAQ:HEQQ) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access